Business
PURE Bioscience Sets Q2 Results Conference Call to Review Progress of FDA Approved PURE Control® Antimicrobial and the Company’s Food Safety Solutions Strategy
PURE Bioscience Sets Q2 Results Conference Call to Review Progress of FDA Approved PURE Control® Antimicrobial and the Company’s Food Safety Solutions Strategy.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented silver dihydrogen citrate (SDC) \n antimicrobial, announced today that the Company will host an investor \n conference call on Wednesday, March 9, 2016 at 1:30pm PST (4:30pm EST).\n \n \n In addition to discussion of second fiscal quarter 2016 results, the \n PURE management team will review the progress made to commercialize SDC \n as a food safety solution.\n \n \n The Participant Dial-In Number for the conference call is \n 1-631-891-4304. Participants should dial in to the call at least five \n minutes before 1:30pm PST (4:30pm EST) on March 9, 2016. The call can \n also be accessed “live” online at http://public.viavid.com/index.php?id=118342.\n \n \n A replay of the webcast will be available on the Company’s website (http://www.purebio.com/about/investor_relations). \n Also, a replay of the conference call will be available by dialing \n 1-877-870-5176 (international participants dial 1-858-384-5517) starting \n March 9, 2016, at 7:30pm Eastern Time through March 16, 2016 at 11:59 pm \n Eastern Time. Please use PIN Number 118342.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, reduced toxicity and it mitigates bacterial \n resistance. PURE is headquartered in El Cajon, California (San Diego \n metropolitan area). Additional information on PURE is available at www.purebio.com.\n \n \n Forward-looking Statements\n \n \n Any statements contained in this press release that do not describe \n historical facts may constitute forward-looking statements as that term \n is defined in the Private Securities Litigation Reform Act of 1995. \n Forward-looking statements inherently involve risks and...